Rocket Lab USA is trading at $49.32, up 6.98%, as shares recover from Thursday’s sharp sell-off.
- Available coverage describes Friday’s rise as a recovery, with no confirmed new company-specific catalyst.
- The Neutron debut delay to 2027 was reported as pressure behind the prior decline, not a clear explanation for Friday’s gain; Monday, November 9 earnings are in focus.
- The S&P 500 and Nasdaq are higher, while industrials are lower.